Fig. 1
From: Methylation-associated Has-miR-9 deregulation in paclitaxel- resistant epithelial ovarian carcinoma
miR-9 expression in EOC and its clinical significances. a. Realtime RT-PCR for miR-9 in ovarian carcinoma cell lines (P = 0.000). b. Realtime RT-PCR for miR-9 in ovarian carcinoma tissues (P = 0.000). The experiments were performed in triplicate. c. Progression free survival time (PFS) of 66 EOC patients by miR-9 level (P = 0.004), MST, median PFS in months. d. Overall survival time (OS) of 66 EOC patients by miR-9 level (P = 0.014). MST, median OS in months